Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-15 Sale | 2023-08-17 4:40 pm | Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Capital GP VII LLC 10% Owner | 822,680 | $0.75 | $617,010 | 1,510,375 (Indirect) | View |
| 2023-07-31 Sale | 2023-08-02 5:05 pm | Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Capital GP VII LLC 10% Owner | 209,400 | $3 | $628,200 | 2,105,909 (Indirect) | View |
| 2023-07-25 Sale | 2023-07-27 4:28 pm | Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Capital GP VII LLC 10% Owner | 39,200 | $2.92 | $114,464 | 2,258,987 (Indirect) | View |
| 2023-07-13 Sale | 2023-07-17 4:13 pm | Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Capital GP VII LLC 10% Owner | 194,700 | $2.4 | $467,280 | 2,285,687 (Indirect) | View |
| 2023-04-13 Sale | 2023-04-17 5:28 pm | Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Capital GP VII LLC 10% Owner | 68,481 | $1.8729 | $128,257 | 2,417,787 (Indirect) | View |
| 2023-04-10 Sale | 2023-04-12 6:44 pm | Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Capital GP VII LLC 10% Owner | 67,537 | $1.7969 | $121,357 | 2,464,234 (Indirect) | View |
| 2023-04-05 Sale | 2023-04-07 4:42 pm | Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Genesis GP LLC OrbiMed Israel GP II L.P. OrbiMed Advisors Israel II Ltd OrbiMed Capital GP VII LLC 10% Owner | 102,630 | $2.163 | $221,994 | 2,510,041 (Indirect) | View |
| 2022-03-22 Purchase | 2022-03-23 08:00 am | Galecto Inc. | GLTO | Lindmark Bertil Chief Medical Officer | 14,604 | $2.16 | $31,545 | 16,604 (Direct) | View |
| 2022-03-22 Purchase | 2022-03-23 08:00 am | Galecto Inc. | GLTO | Schambye Hans T. Chief Executive Officer | 5,000 | $2.15 | $10,750 | 52,428 (Direct) | View |
| 2021-12-03 Purchase | 2021-12-06 08:00 am | Galecto Inc. | GLTO | Winslow Garrett General Counsel | 2,000 | $2.48 | $4,960 | 4,000 (Direct) | View |
| 2021-12-03 Purchase | 2021-12-06 08:00 am | Galecto Inc. | GLTO | Freve Jonathan Chief Financial Officer | 4,000 | $2.49 | $9,960 | 12,000 (Direct) | View |
| 2021-11-09 Purchase | 2021-11-10 08:00 am | Galecto Inc. | GLTO | Schambye Hans T. Chief Executive Officer | 4,500 | $3.5 | $15,750 | 47,428 (Direct) | View |
| 2021-11-08 Purchase | 2021-11-09 08:00 am | Galecto Inc. | GLTO | Freve Jonathan Chief Financial Officer | 3,000 | $3.4 | $10,200 | 8,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-14 Option Award | 2023-06-15 4:00 pm | N/A 2033-06-13 | Galecto Inc. | GLTO | Shapiro David Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:00 pm | N/A 2033-06-13 | Galecto Inc. | GLTO | Prener Anne Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:00 pm | N/A 2033-06-13 | Galecto Inc. | GLTO | Munshi Amit Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:00 pm | N/A 2033-06-13 | Galecto Inc. | GLTO | GOLDFISCHER CARL Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2023-06-17 Option Award | 2023-06-15 4:00 pm | N/A 2033-06-13 | Galecto Inc. | GLTO | Dallas Jayson Donald Alexander Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:00 pm | N/A 2033-06-13 | Galecto Inc. | GLTO | Khuong Chau Quang Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 4:00 pm | N/A 2033-01-03 | Galecto Inc. | GLTO | Schambye Hans T. Chief Executive Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 4:00 pm | N/A 2033-01-03 | Galecto Inc. | GLTO | Oestreich Stephanie Chief Business Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 4:00 pm | N/A 2033-01-03 | Galecto Inc. | GLTO | Pedersen Anders Chief Operating Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 4:00 pm | N/A 2033-01-03 | Galecto Inc. | GLTO | Freve Jonathan Chief Financial Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 4:00 pm | N/A 2033-01-03 | Galecto Inc. | GLTO | Winslow Garrett General Counsel | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 4:00 pm | N/A 2033-01-03 | Galecto Inc. | GLTO | Lindmark Bertil Chief Medical Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:00 pm | N/A 2032-06-13 | Galecto Inc. | GLTO | Munshi Amit Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:00 pm | N/A 2032-06-13 | Galecto Inc. | GLTO | Shapiro David Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:00 pm | N/A 2032-06-13 | Galecto Inc. | GLTO | Prener Anne Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:00 pm | N/A 2032-06-13 | Galecto Inc. | GLTO | Khuong Chau Quang Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:00 pm | N/A 2032-06-13 | Galecto Inc. | GLTO | GOLDFISCHER CARL Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 4:00 pm | N/A 2032-06-13 | Galecto Inc. | GLTO | Dallas Jayson Donald Alexander Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-15 4:00 pm | N/A 2032-02-14 | Galecto Inc. | GLTO | Oestreich Stephanie Chief Business Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 5:00 pm | N/A 2032-01-03 | Galecto Inc. | GLTO | Schambye Hans T. Chief Executive Officer | 287,500 | $0 | 287,500 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 5:00 pm | N/A 2032-01-03 | Galecto Inc. | GLTO | Lindmark Bertil Chief Medical Officer | 118,750 | $0 | 118,750 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 5:00 pm | N/A 2032-01-03 | Galecto Inc. | GLTO | Pedersen Anders Chief Operating Officer | 118,750 | $0 | 118,750 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 5:00 pm | N/A 2032-01-03 | Galecto Inc. | GLTO | Winslow Garrett General Counsel | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 5:00 pm | N/A 2032-01-03 | Galecto Inc. | GLTO | Freve Jonathan Chief Financial Officer | 118,750 | $0 | 118,750 (Direct) | View |
| 2021-11-17 Option Award | 2021-11-19 5:00 pm | N/A 2031-11-16 | Galecto Inc. | GLTO | Khuong Chau Quang Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-11-17 Option Award | 2021-11-19 5:00 pm | N/A 2031-11-16 | Galecto Inc. | GLTO | GOLDFISCHER CARL Director | 18,000 | $0 | 18,000 (Direct) | View |